Anxiety, depression, and quality of life among HIV positive injection drug users in Ukraine, 2017
Author(s) -
Marta Vasylyev,
Hayk Davtyan,
Olga Denisiuk,
Joshua Chadwick Jayaraj,
Тетяна Ігорівна Коваль,
Анна Іванівна Піддубна,
Maryana Sluzhynska,
Oleksandra Sluzhynska,
Fiona Mulcahy
Publication year - 2019
Publication title -
the journal of infection in developing countries
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.322
H-Index - 49
eISSN - 2036-6590
pISSN - 1972-2680
DOI - 10.3855/jidc.11295
Subject(s) - anxiety , depression (economics) , human immunodeficiency virus (hiv) , drug , quality of life (healthcare) , psychology , psychiatry , medicine , clinical psychology , virology , psychotherapist , economics , macroeconomics
People who inject drugs (PWID) are one of the key populations most vulnerable to HIV infection, with 28 times higher prevalence compared to the rest of the population. PWID are known to have many physical, psychological and lifestyle challenges that can influence access to care. Depression is common among PWID living with HIV. It has major effect on health-related quality of life (HRQoL) and is influencing adherence to antiretroviral therapy. This study was conducted to explore how anxiety and depression affect HRQoL among HIV-positive PWID in Ukraine. It will provide knowledge for the further policy development.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom